Intuitive Surgical

Intuitive Surgical Q4 Earnings Preview: EPS $2.27, Revenue $2.76B, Up 2.7% and 14.5% Y/Y Respectively.

Booking Holdings

Analog Devices

JPMorgan Nasdaq Equity Premium Income ETF

ETF Inflows: JPMorgan Nasdaq Equity Premium Income ETF, Intuitive Surgical, Booking Holdings, Analog Devices

直觉外科

Intuitive Surgical's stock price triggers Bollinger Bands narrowing and KDJ Death Cross.

Intuitive Surgical Shares Fall on Softer 2026 Outlook

Intuitive Surgical Boosts Q4 Revenue Guidance Amid Growth Concerns

Catalyst<ul> <li>Most analysts rate ISRG Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state, and we need to pay attention to the risk of decline.</li> <li>Recent technical signals are bearish, with 2 negative signals including MACD Golden Cross and Marubozu White, indicating downward bias.</li> <li>Fund flow analysis shows overall negative net outflow, with mixed trends across different order sizes.</li></ul>

Key Factors

Intuitive Surgical reported Q4 2025 consensus EPS of $2.27 and revenue of $2.76B, representing year-over-year increases of 2.7% and 14.5% respectively.Intuitive Surgical's 2025 revenue reached $10.06 billion with worldwide procedures increasing by 19%, establishing a financial foundation for its strategic shift to surgical AI infrastructure.Intuitive Surgical received FDA clearance for AI-enhanced navigation on its Ion platform, marking a strategic pivot toward owning the intelligence layer of minimally invasive care.

Recent Updates

ISRG News